The decision came as an initial win for a broad coalition of academic institutions that had argued the policy jeopardized ...

In October, Jay Bhattacharya, then a health economist at Stanford University, posted on X: “If you favor government control of misinformation, you are an enemy of free speech.” On Wednesday ...

The grant was canceled after a change in NIH policy to not “prioritize research activities that focus on gaining scientific knowledge on why individuals are hesitant to be vaccinated and/or ...

This is why academic organizations particularly engage in the grants, as there is more of an organizational capacity to work with NIH processes at scale. It is unclear what private funders would ...

President Donald Trump has already tried to slash $4 billion in NIH research grants, an effort which is currently tied up in court. Meanwhile, Kennedy has been raising concerns among other public ...

The National Institutes of Health in Bethesda. Photo Credit: Grandbrothers /Getty Images Former National Institutes of Health (NIH) Director Francis Collins said Wednesday a “great cloud looms ...

The NIH oversees tens of billions of dollars annually in public health research funding. AP Data on the number of transgender men who give birth in the US is sparse, but one study by the ...

Kennedy Jr. NIH has cut one mRNA-vaccine grant. Will more follow? Such large-scale grant terminations are unprecedented; the agency typically cancels only a few dozen projects each year in ...

March 26 (Reuters) - The U.S. Senate on Tuesday confirmed President Donald Trump's nominees Martin Makary and Jay Bhattacharya as heads of the Food and Drug Administration and the National ...

The Senate on Tuesday confirmed health researcher Jay Bhattacharya as the next leader of the National Institutes of Health (NIH). Bhattacharya was confirmed on a party- line vote, 53 to 47.

ORIC-944 is a potent, highly selective, orally bioavailable, allosteric inhibitor of PRC2 that demonstrates best-in-class drug properties, including potency, solubility, and pharmacokinetics, with ...

Bhattacharya, a professor of medicine at Stanford University and a research associate at the National Bureau of Economics Research, has been a vocal critic of the NIH. He gained attention as a co ...